34.42
price up icon2.75%   0.92
after-market Dopo l'orario di chiusura: 34.55 0.13 +0.38%
loading

Viking Therapeutics Inc Borsa (VKTX) Ultime notizie

pulisher
06:28 AM

Viking Therapeutics Inc. Stock Analysis and ForecastUnmatched market gains - PrintWeekIndia

06:28 AM
pulisher
03:01 AM

Behind the Scenes of Viking Therapeutics's Latest Options Trends - Benzinga

03:01 AM
pulisher
12:57 PM

VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales - MSN

12:57 PM
pulisher
12:54 PM

Is Viking Therapeutics Inc. a good long term investmentPhenomenal investment performance - PrintWeekIndia

12:54 PM
pulisher
11:49 AM

H.C. Wainwright Reiterates a Buy Rating on Viking Therapeutics (VKTX), Sets a $102 PT - MSN

11:49 AM
pulisher
10:15 AM

Viking Therapeutics Q2: Confidently Continuing The Recovery (NASDAQ:VKTX) - Seeking Alpha

10:15 AM
pulisher
09:13 AM

Analysts Are Bullish on These Healthcare Stocks: Thermo Fisher (TMO), Viking Therapeutics (VKTX) - The Globe and Mail

09:13 AM
pulisher
08:10 AM

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q2 2025 Earnings Call Transcript - Insider Monkey

08:10 AM
pulisher
06:32 AM

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX) and Gilead Sciences (GILD) - The Globe and Mail

06:32 AM
pulisher
03:45 AM

Viking Therapeutics Receives Buy Rating Amid Promising Clinical Developments and Strategic Initiatives - TipRanks

03:45 AM
pulisher
02:52 AM

What drives Viking Therapeutics Inc. stock priceAccelerated wealth expansion - PrintWeekIndia

02:52 AM
pulisher
01:22 AM

Viking Therapeutics stock maintains Buy rating at Stifel on obesity drug potential - Investing.com Australia

01:22 AM
pulisher
Jul 24, 2025

Viking Therapeutics’ Earnings Call: Clinical Advances Amid Financial Challenges - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Therapeutics EPS miss sends shares down 7% - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Therapeutics Surges to 433rd in Trading Volume as Strategic Partnership and Clinical Success Fuel Stock Rally - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Rapidly Advancing Oral And Injectable VK2735 For Obesity - insights.citeline.com

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Therapeutics (VKTX) Stock Rating Maintained by Raymond James | VKTX Stock News - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Therapeutics Q2 Earnings Miss Estimates, R&D Expenses Rise - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Therapeutics stock rating reiterated by Cantor Fitzgerald at $104 - Investing.com Canada

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Therapeutics, Inc. (VKTX): A Bull Case Theory - Insider Monkey

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Therapeutics outlines Phase III VANQUISH trial enrollment of 5,600 patients while advancing oral obesity program - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Therapeutics Inc (VKTX) Q2 2025 Earnings Call Highlights: Navigating Increased R&D ... - Yahoo Finance

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Therapeutics Inc (VKTX) Q2 2025 Earnings Call Highlights: - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Viking Therapeutics Advances Clinical Pipeline Amid Financial Losses - TipRanks

Jul 24, 2025
pulisher
Jul 23, 2025

Viking Therapeutics' Q2 2025 Earnings Call: Unpacking Key Contradictions in Phase III Study Strategy - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Viking Therapeutics Inc. stockSuperior stock selection - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics Posts Wider Q2 Loss - AOL.com

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics EPS miss sends shares down 7% (VKTX:NASDAQ) - Seeking Alpha

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics Stock Slides After Company Misses Q2 Earnings Estimates - Benzinga

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics (VKTX) Reports Q2 Loss, Misses EPS Expectati - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics, Inc. SEC 10-Q Report - TradingView

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics shares fall as Q2 loss exceeds estimates By Investing.com - Investing.com India

Jul 23, 2025
pulisher
Jul 23, 2025

Viking (VKTX) Q2 2025 Earnings Call Transcript - Mitrade

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics reports Q2 EPS (58c), consensus (44c) - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update | VKTX Stock News - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Finansavisen

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics (VKTX) Options Activity Surges Ahead of Earnings | VKTX Stock News - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics to Report Q2 2025 Financial Results on July 23, 2025 - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics, Inc. (NASDAQ:VKTX) institutional owners may be pleased with recent gains after 38% loss over the past year - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

Viking Therapeutics to Report Financial Results for Second Quarter 2025 on July 23, 2025 - Finansavisen

Jul 23, 2025
pulisher
Jul 22, 2025

Viking Therapeutics (VKTX) Set to Release Q2 Earnings Results - GuruFocus

Jul 22, 2025
pulisher
Jul 22, 2025

Better Growth Buy: Eli Lilly vs. Viking Therapeutics - Mitrade

Jul 22, 2025
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):